Abilify and Emsam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Emsam (selegiline). Common drug interactions include incontinence among females and cervical vertebral fracture among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Emsam. It is created by eHealthMe based on reports of 91 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Emsam?

Emsam has active ingredients of selegiline. It is often used in depression. eHealthMe is studying from 1,875 Emsam users. Check the latest studies of Emsam.



On Jul, 15, 2026

91 people who take Abilify and Emsam together, and have interactions are studied.

Abilify and Emsam drug interactions.

What are the common drug interactions of Abilify and Emsam, by gender? *:

female:

  1. Incontinence (lack of moderation or self-control)
  2. Increased appetite
  3. Irritability
  4. Ligament sprain (ligament stretched)
  5. Menstruation irregular
  6. Mood altered (changes in mood)
  7. Muscle contractions involuntary (uncontrolled muscle contraction)
  8. Muscle tightness
  9. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  10. Phobia (fear)

male:

  1. Cervical vertebral fracture
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Local swelling (swelling at the site of some application of substance or injury)
  4. Memory impairment
  5. Muscle disorder (muscle disease)
  6. Overdose
  7. Rash generalised (rash on most of body parts)
  8. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  9. Application site discolouration
  10. Application site pain

What are the common drug interactions of Abilify and Emsam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Application site rash

30-39:

  1. Weight increased
  2. Cervical vertebral fracture
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Cardiac failure
  5. Suicidal ideation
  6. Fall
  7. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
  8. Myositis (inflammation of the muscles)
  9. Obsessive rumination (thinking and worry or rumination is an inability to gain control over recurrent, distressing thoughts, images)
  10. Papilloma viral infection

40-49:

  1. Abdominal discomfort
  2. Application site rash
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Embolic cerebral infarction (brain stroke due to obstruction of an artery)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Weight increased
  7. Cystitis (inflammation of the wall of the bladder)
  8. Hospitalisation
  9. Memory impairment
  10. Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)

50-59:

  1. Abnormal faeces (abnormal stool)
  2. Application site discolouration
  3. Drug effect decreased
  4. Alanine aminotransferase decreased
  5. Aspartate aminotransferase decreased
  6. Blood calcium decreased
  7. Blood creatinine increased
  8. Blood potassium decreased
  9. Blood urea increased
  10. Delusion (a false belief or opinion)

60+:

  1. Memory impairment
  2. Activities of daily living impaired
  3. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  4. Increased appetite
  5. Rash generalised (rash on most of body parts)
  6. Suicidal ideation
  7. Weight increased
  8. Blood glucose increased
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 27 people, 29.67%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 18 people, 19.78%
  3. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 8 people, 8.79%
  4. Stress And Anxiety: 6 people, 6.59%
  5. Sleep Disorder: 6 people, 6.59%
  6. Bipolar Disorder (mood disorder): 5 people, 5.49%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Emsam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Emsam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Emsam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emsam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and selegiline (the active ingredients of Abilify and Emsam, respectively), and Abilify and Emsam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: